Proteomics International Laboratories has secured a patent from the Japan Patent Office for the PromarkerEndo test for ...

A court has approved the $305m sale of 23andMe’s assets to a nonprofit led by former 23andMe CEO Anne Wojcicki.

Nanostics has secured funding from Genome Canada and Genome Alberta to expedite the ClarityDX Prostate test integration into ...

Glaukos has secured EU Medical Device Regulation (EU-MDR) certification for its iStent infinite, along with other MIGS ...

Enterra Medical has commenced the randomised, multi-centre NAVIGATE study, designed to assess Gastric Electrical Stimulation ...

A professor from the University of Sheffield has received over £0.39m ($0.45m) in funding from Breast Cancer Now to develop a ...

Medical Research Council (MRC) has launched a new £50m ($68.6m) centre spread across collaborator sites in the UK to develop ...

The FDA label update boosts GE HealthCare’s Vizamyl to a market advantage despite the emergence of blood-based tests.

ITM and Swiss-based Debiopharm have announced the imaging of the first subject in a new study arm (Part D) of the Phase I/II ...

Vivasure Medical has submitted an application seeking premarket approval from the FDA for its PerQseal Elite vascular closure ...

MedTech Europe has issued a statement calling on European policymakers to exempt medical technologies from any trade tariffs ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance to Stryker’s Incompass Total Ankle System.